The purpose of this modification is to fund option year two (2) clin 2201 cgmp adjuvant: clinical or commercial scale bulk lot(s). QTY of 1 for unit price of $8,609,815. The period of performance…
Ended Awarded
- Contract number
- 75A50120F33012
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $8,609,815
Award facts
- Contract value 100% obligated
- $8,609,815.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company. The purpose of this $8,609,815.00 firm-fixed-price contract modification is to fund Option Year 2 for the production of a CGMP (Current Good Manufacturing Practice) adjuvant at the clinical or commercial scale. The overall contract is part of the Pandemic Influenza Preparedness and Response 2016-2021 Indefinite Delivery Contract vehicle. The period of performance for this option year is August 22, 2020 through August 21, 2021. The contract does not have a set-aside designation.
Description
The purpose of this modification is to fund option year two (2) clin 2201 cgmp adjuvant: clinical or commercial scale bulk lot(s). QTY of 1 for unit price of $8,609,815. The period of performance remains august 22, 2020 thru august 21, 2021. All
Quick answers
Who was awarded contract 75A50120F33012?
75A50120F33012 was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 1, 2020.
How much is contract 75A50120F33012 worth?
The government has obligated $8,609,815 on 75A50120F33012.
Is contract 75A50120F33012 an order under another contract?
Yes. 75A50120F33012 is a delivery order under HHSO100201600004I, an indefinite delivery contract, on Pandemic Influenza Preparedness and Response 2016-2021.
Was contract 75A50120F33012 competed?
The extent of competition for 75A50120F33012 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award